Cardiovascular Systems (FRA:R7Y1) COGS-to-Revenue : 0.30 (As of Dec. 2022)

View and export this data going back to 2012. Start your Free Trial

What is Cardiovascular Systems COGS-to-Revenue?

Cardiovascular Systems's Cost of Goods Sold for the three months ended in Dec. 2022 was €17.4 Mil. Its Revenue for the three months ended in Dec. 2022 was €58.0 Mil.

Cardiovascular Systems's COGS to Revenue for the three months ended in Dec. 2022 was 0.30.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Cardiovascular Systems's Gross Margin % for the three months ended in Dec. 2022 was 69.96%.

Cardiovascular Systems COGS-to-Revenue Historical Data

The historical data trend for Cardiovascular Systems's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiovascular Systems COGS-to-Revenue Chart

Cardiovascular Systems Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

COGS-to-Revenue

Get a 7-Day Free Trial

0.18

0.19

0.21

0.24

0.27

Cardiovascular Systems Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
COGS-to-Revenue	Get a 7-Day Free Trial															0.31	0.26	0.26	0.28	0.30

Cardiovascular Systems COGS-to-Revenue Calculation

Cardiovascular Systems's COGS to Revenue for the fiscal year that ended in Jun. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	60.014	/	223.466
	=	0.27

Cardiovascular Systems's COGS to Revenue for the quarter that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	17.428	/	58.012
	=	0.30

Cardiovascular Systems (FRA:R7Y1) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Cardiovascular Systems's Gross Margin % for the three months ended in Dec. 2022 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	17.428 / 58.012
	=	69.96 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cardiovascular Systems COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cardiovascular Systems's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardiovascular Systems (FRA:R7Y1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cardiovascular Systems Inc (FRA:R7Y1) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1225 Old Highway 8 Northwest, Saint Paul, MN, USA, 55112-6416

Website

https://www.csi360.com

Cardiovascular Systems Inc is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generate the vast majority of its revenue in the United States.

Cardiovascular Systems (FRA:R7Y1) Headlines

No Headlines